Neurol. praxi. 2022;23(3):192-197 | DOI: 10.36290/neu.2022.010

Daytime sleepiness in a neurologist's office

doc. MUDr. Eva Feketeová, PhD.
Neurologická klinika UPJŠ LF a UN LP Košice

Daytime sleepiness (DS) poses a serious risk to the affected individual in the form of difficult employment and reduced quality of life and, depending on its cause, also metabolic and cardiovascular consequences. The work analyzes the nature of sleepiness depending on its cause, diagnostic procedures and therapeutic options. On the example of five case reports points out the differences in clinical manifestation of sleepiness in narcolepsy type 1, Klein-Levin syndrome, epilepsy, multiple sclerosis and osmotic demyelinating syndrome, it demonstrates the application of diagnostic and therapeutic options in clinical practice.

Keywords: excessive daytime sleepiness, fatigue, central disorders of hypersomnolence, narcolepsy.

Received: February 6, 2022; Revised: March 4, 2022; Accepted: March 13, 2022; Prepublished online: March 13, 2022; Published: June 16, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Feketeová E. Daytime sleepiness in a neurologist's office. Neurol. praxi. 2022;23(3):192-197. doi: 10.36290/neu.2022.010.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. American Academy of Sleep Medicine (AASM). International classification of sleep disorders - third edition (ICSD-3). 3rd ed. Darien, Illinois; 2014.
    2. Andlauer O, Moore IV H, Hong SC, et al. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy. Sleep. 2012;35(9):1247-1255. doi: 10.5665/sleep.2080. Go to original source... Go to PubMed...
    3. Bassetti CLA, Kallweit U, Vignatelli L, et al. European guideline and expert statements on the management of narcolepsy in adults and children. J Sleep Res. 2021;30(6). doi: 10.1111/ene.14888. Go to original source... Go to PubMed...
    4. Becker PM, Sharon D. Mood disorders in restless legs syndrome (Willis-Ekbom disease). J Clin Psychiatry. 2014;75(7):e679-694. doi: 10.4088/JCP.13r08692. Go to original source... Go to PubMed...
    5. Cairns A, Trotti LM, Bogan R. Demographic and nap-related variance of the MSLT: results from 2,498 suspected hypersomnia patients: Clinical MSLT variance. Sleep Med. 2019;55:115-123. doi: 10.1016/j.sleep.2018.12.013. Go to original source... Go to PubMed...
    6. Chaudhuri A, Behan PO. Fatigue in neurological disorders. Lancet. 2004;363(9413):978-988. doi: 10.1016/S0140-6736(04)15794-2. Go to original source... Go to PubMed...
    7. Dagan Y. Circadian rhythm sleep disorders (CRSD). Sleep Med Rev. 2002;6(1):45-55. doi: 10.1053/smrv.2001.0190. Go to original source... Go to PubMed...
    8. Donjacour CEHM, Aziz NA, Overeem S, et al. Glucose and fat metabolism in narcolepsy and the effect of sodium oxybate: a hyperinsulinemic-euglycemic clamp study. Sleep. 2014;37(4):795-801. doi: 10.5665/sleep.3592. Go to original source... Go to PubMed...
    9. El-Solh AA, Rudraraju A, Pasrija D, Bui H. Pharmacotherapy of residual excessive sleepiness among continuous positive airway pressure (CPAP) treated patients with sleep apnea. Expert Opin Pharmacother. 2022; doi:10.1080/14656566.2022.2029408. Go to original source... Go to PubMed...
    10. Hjollund NH, Andersen JH, Bech P. Assessment of fatigue in chronic disease: A bibliographic study of fatigue measurement scales. Health Qual Life Outcomes. 2007;5. doi: 10.1186/1477-7525-5-12. Go to original source... Go to PubMed...
    11. Janson C, Gislason T, De Backer W, et al. Daytime sleepiness, snoring and gastro-oesophageal reflux amongst young adults in three European countries. J Intern Med. 1995;237(3):277-285. doi: 10.1111/j.1365-2796.1995.tb01176.x Go to original source... Go to PubMed...
    12. Johns MW. A new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep. 1991;14(6):540-545. doi: 10.1093/sleep/14.6.540. Go to original source... Go to PubMed...
    13. Lammers GJ, Bassetti CLA, Dolenc-Groselj L, et al. Diagnosis of central disorders of hypersomnolence: A reappraisal by European experts. Sleep Med Rev. 2020;52. doi: 10.1016/j.smrv.2020.101306. Go to original source... Go to PubMed...
    14. Nevsimalova S, Susta M, Prihodova I, et al. Idiopathic hypersomnia: a homogeneous or heterogeneous disease? Sleep Med. 2021;80:86-91. doi: 10.1016/j.sleep.2021.01.031. Go to original source... Go to PubMed...
    15. Nishiyama T, Mizuno T, Kojima M, et al. Criterion validity of the Pittsburgh Sleep Quality Index and Epworth Sleepiness Scale for the diagnosis of sleep disorders. Sleep Med. 2014;15(4):422-429. doi: 10.1016/j.sleep.2013.12.015. Go to original source... Go to PubMed...
    16. Overeem S, van Nues SJ, van der Zande WL, et al. The clinical features of cataplexy: a questionnaire study in narcolepsy patients with and without hypocretin-1 deficiency. Sleep Med. 2011;12(1):12-18. doi: 10.1016/j.sleep.2010.05.010. Go to original source... Go to PubMed...
    17. Plante DT. Sleep propensity in psychiatric hypersomnolence: A systematic review and meta-analysis of multiple sleep latency test findings. Sleep Med Rev. 2017;31:48-57. doi: 10.1016/j.smrv.2016.01.004. Go to original source... Go to PubMed...
    18. Roehrs T, Zorick F, Sicklesteel J, et al. Excessive daytime sleepiness associated with insufficient sleep. Sleep. 1983;6(4):319-325. doi: 10.1093/sleep/6.4.319. Go to original source... Go to PubMed...
    19. Rosenthal LD, Dolan DC. The Epworth sleepiness scale in the identification of obstructive sleep apnea. J Nerv Ment Dis. 2008;196(5):429-431. doi: 10.1097/NMD.0b013e31816ff3bf. Go to original source... Go to PubMed...
    20. Roh EY, Park MH, Park H, et al. Association of HLA-DR and - DQ Genes with Narcolepsy in Koreans: Comparison with Two Control Groups, Randomly Selected Subjects and DRB1*1501-DQB1*0602-Positive Subjects. Hum Immunol. 2006;67(9):749-755. doi: 10.1016/j.humimm.2006.03.024. Go to original source... Go to PubMed...
    21. Saaresranta T, Hedner J, Bonsignore MR, et al. Clinical phenotypes and comorbidity in European sleep apnoea patients. PLoS One. 2016;11(10). doi: 10.1371/journal.pone.0163439. Go to original source... Go to PubMed...
    22. Šonka K, Šusta M, Billiard M. Narcolepsy with and without cataplexy, idiopathic hypersomnia with and without long sleep time: A cluster analysis. Sleep Med. 2015;16(2):225-231. doi: 10.1016/j.sleep.2014.09.016. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.